Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

被引：0
|
作者：
Ahmed, Sairah [1 ]
Lin, Heather [1 ]
Baladandayuthapani, Veera [1 ]
Khan, Mubeen A. [1 ]
Lu, Gary
Rondon, Gabriela [1 ]
Qureshi, Sofia [1 ]
Dinh, Yvonne T. [1 ]
Bashir, Qaiser [1 ]
Shah, Nina [1 ]
Parmar, Simrit [2 ]
Hosing, Chitra M. [1 ]
Popat, Uday [1 ]
Giralt, Sergio A.
Orlowski, Robert Z. [3 ]
Shah, Jatin J.
Champlin, Richard [1 ]
Qazilbash, Muzaffar H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therap, Houston, TX 77030 USA
[2] Mem Sloan Kettering Canc Ctr, Allogene Bone Marrow Transplant Serv Med, New York, NY 10021 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [41] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Schilling, G.
    Hansen, T.
    Shimoni, A.
    Zabelina, T.
    Simon-Perez, J-A
    Gutierrez, N. C.
    Bethge, W.
    Liebisch, P.
    Schwerdtfeger, R.
    Bornhaeuser, M.
    Otterstetter, S.
    Penas, E. M. M.
    Dierlamm, J.
    Ayuk, F.
    Atanackovic, D.
    Bacher, U.
    Bokemeyer, C.
    Zander, A.
    Miguel, J. S.
    Nagler, A.
    Kroeger, N.
    LEUKEMIA, 2008, 22 (06) : 1250 - 1255
  • [42] Depth of response post autologous hematopoietic stem cell transplantation (auto-HCT) to predict outcome in high risk multiple myeloma (MM).
    Hu, Bei
    Sasaki, Koji
    Bashir, Qaiser
    Shah, Nina
    Patel, Krina K.
    Popat, Uday R.
    Hosing, Chitra
    Nieto, Yago
    Lin, Pei
    Delgado, Ruby
    Jorgensen, Jeffrey L.
    Shah, Jatin J.
    Manasanch, Elisabet Esteve
    Weber, Donna M.
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently
    Kazmi, Syed
    Lu, Gary
    Shah, Nina
    Bashir, Qaiser
    Parmar, Simrit
    Orlowski, Robert Z.
    Shah, Jatin J.
    Hosing, Chitra M.
    Popat, Uday
    Dinh, Yvonne T.
    Qureshi, Sofia
    Rondon, Gabriela
    Giralt, Sergio
    Champlin, Richard
    Qazilbash, Muzaffar H.
    BLOOD, 2011, 118 (21) : 1778 - 1778
  • [44] Impact of peripheral blood stem cell recruitment on autologous haematopoietic stem cell transplantation outcome in multiple myeloma
    Michallet, M
    Le, QH
    Michallet, AS
    Thiebaut, A
    Tavernier, E
    Troncy, J
    Thomas, X
    Chelghoum, Y
    Praire, A
    Gadolet, E
    Nicolini, F
    Clapisson, G
    Philip, I
    BONE MARROW TRANSPLANTATION, 2005, 35 : S248 - S249
  • [45] Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
    Sasaki, Koji
    Saliba, Rima
    Lu, Gary
    Shah, Nina
    Bashir, Qaiser
    Patel, Krina
    Bock, Fabian
    Parmar, Simrit
    Hosing, Chitra
    Popat, Uday R.
    Delgado, Ruby
    Rondon, Gabriela
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S202 - S203
  • [46] Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: IMPACT of Age
    Dhakal, Binod
    Nelson, Ariel
    Murthy, Guru Subramanian Guru
    Fraser, Raphael
    Eastwood, Daniel
    Hamadani, Mehdi
    D'Souza, Anita
    Hari, Parameswaran
    BLOOD, 2016, 128 (22)
  • [47] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Gertz, Marie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
  • [48] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT) IN HIGH-RISK MYELOMA (MM)
    MARIT, G
    PICO, JL
    BOIRON, JM
    FOURES, C
    BERNARD, P
    BROUSTET, A
    REIFFERS, J
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 558 - 558
  • [49] Using genomics to identify high-risk myeloma after autologous stem cell transplantation
    Shaughnessy, JD
    Barlogie, B
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) : 77 - 80
  • [50] Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
    Kazmi, Syed M.
    Nusrat, Maliha
    Gunaydin, Hilal
    Cornelison, Amanda M.
    Shah, Nina
    Kebriaei, Partow
    Nieto, Yago
    Parmar, Simrit
    Popat, Uday R.
    Oran, Betul
    Shah, Jatin J.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (11): : 687 - 693
12345